Atrium Levine Cancer Institute is a clinical research site located in Charlotte, North Carolina, United States 28203.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Atrium Levine Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Relapse Multiple Myeloma, Refractory Multiple Myeloma.
Sponsors: Multiple Myeloma Research Consortium.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Atrium Levine Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Atrium Levine Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Relapse Multiple Myeloma, Refractory Multiple Myeloma.
Atrium Levine Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.